Physician profile
Jasminder Kaur
NPI 1770746968
$752.32
in general payments reported to CMS, 2019-2025
11 companies · $41.14 in 2025
The $41.14 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $68.45 · 2022: $110 · 2023: $409 · 2024: $124 · 2025: $41.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.02 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $370.32 | 2023 | |
| Zimvie INC. | $101.44 | 2023-2024 | |
| Philips North America LLC | $97.62 | 2022 | |
| Patterson Companies, INC. | $33.78 | 2024 | |
| Dentsply Sirona INC | $29.28 | 2024-2025 | Nupro, Suresmile |
| Voco America INC. | $26.51 | 2021-2023 | Calcimol Lc, Voco Profluorid Varnish, Futurabond U |
| Solventum Corporation | $25.86 | 2025 | 3m Scotchbond, 3m Espe Filtek Supreme Ultra Universal Restorative, Clarity Aligners |
| Zimmer Biomet Holdings, INC. | $25.40 | 2021 | |
| 3m Company | $15.83 | 2021 | |
| Align Technology, INC. | $14.05 | 2021 | |
| Dexcel Pharma Technologies Ltd. | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasminder Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.